AKER BIOMARINE HUMAN INGREDIENTS AS: årsregnskap 2024 vs 2023
Grew 910328% on revenue, slipped into loss, fresh owner capital
approved 2025-06-20; registry 2025-07-17; journal 2025 673050
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for AKER BIOMARINE HUMAN INGREDIENTS AS. Revenue 10.6k NOK → 96.64m NOK (+910328.5%). Net result +5.44m NOK → -39.81m NOK. Equity 7.31m NOK → -14.04m NOK.
On the constructive side: revenue rose; owners injected capital. Pressures included: operating result weakened; fell into a net loss; equity eroded.
Also worth watching: thin equity buffer; book investments changed. All figures are taken from the published annual accounts for AKER BIOMARINE HUMAN INGREDIENTS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 10.6k NOK to 96.64m NOK (+910328.5% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 2 520 NOK → 20.98m NOK (+20.98m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result +5 911 NOK → -36.71m NOK (op. margin 55.7% → -38.0%). Calculated
-
↓
Fell into a net loss
Net result flipped from 5.44m NOK profit to a loss of 39.81m NOK. Calculated
-
↓
Equity eroded
Book equity 7.31m NOK → -14.04m NOK (equity ratio 6.4% → -12.4%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -12.4% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Book investments changed
Investment / intangible book value 4 107 NOK → 11 NOK. Reported fact